Agenus Inc. (AGEN) grants director 50,000 stock options at $7.78
Rhea-AI Filing Summary
Agenus Inc. director Susan B. Hirsch received a grant of stock options covering 50,000 shares of common stock on August 5, 2026. The options have an exercise price of $7.7800 per share, expire on August 5, 2036, and were awarded under the 2019 Amended and Restated Equity Incentive Plan. They vest over three years, with one-third vesting on the first anniversary of the grant date and the remaining two-thirds in two equal annual installments.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hirsch Susan B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 50,000 shares (Direct)
Footnotes (1)
- F1. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.
Key Figures
Stock options granted: 50,000 options
Exercise price: $7.7800 per share
Expiration date: August 5, 2036
+2 more
5 metrics
Stock options granted
50,000 options
Grant to director Susan B. Hirsch on 2026-08-05
Exercise price
$7.7800 per share
Exercise price of the stock option award
Expiration date
August 5, 2036
Expiration of the granted stock options
Underlying shares
50,000 shares
Common stock underlying the option grant
Vesting period
3 years
One-third after one year, remaining two-thirds in two equal annual installments
Key Terms
Stock Option, Equity Incentive Plan, vesting
3 terms
Stock Option financial
"security title reported as Stock Option for derivative award"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Equity Incentive Plan financial
"awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting financial
"and vest over three (3) years, with one-third (1/3) vesting on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock options did Agenus (AGEN) director Susan B. Hirsch receive?
Susan B. Hirsch received a grant of 50,000 stock options on August 5, 2026, covering Agenus common shares. The award is part of her director compensation under the company’s 2019 Amended and Restated Equity Incentive Plan.
What is the exercise price and expiration date of Susan B. Hirsch’s Agenus (AGEN) options?
The options have an exercise price of $7.7800 per share and expire on August 5, 2036. Hirsch can purchase Agenus common stock at this price any time before the expiration, subject to the options’ vesting schedule.
How do Susan B. Hirsch’s Agenus (AGEN) stock options vest?
The 50,000 Agenus options vest over three years. One-third vests on the first anniversary of the grant date, and the remaining two-thirds vest in two equal annual installments over the following two years.
Is Susan B. Hirsch’s Agenus (AGEN) Form 4 transaction a market purchase or a grant?
The Form 4 reports a grant/award acquisition of stock options, not a market purchase. The options were awarded at $0.00 cost, with a fixed exercise price of $7.7800, as equity compensation under Agenus’s 2019 equity incentive plan.
How many Agenus (AGEN) stock options does Susan B. Hirsch hold after this grant?
After this reported transaction, Susan B. Hirsch holds 50,000 stock options directly. These options are exercisable into 50,000 shares of Agenus common stock as they vest and before their August 5, 2036 expiration.